Brief: Bioventus Q1 Sales Rose 43.4 Percent To $117.3 Mln
May 10 (Reuters) - Bioventus Inc BVS.O :
* BIOVENTUS REPORTS FIRST QUARTER RESULTS; REAFFIRMS
FULL-YEAR
2022 FINANCIAL GUIDANCE
* Q1 SALES ROSE 43.4 PERCENT TO $117.3 MILLION
* Q1 REVENUE VIEW $117.7 MILLION -- REFINITIV IBES DATA
* REAFFIRMS FULL YEAR 2022 FINANCIAL GUIDANCE
Source text for Eikon: ID:nGNX56YBxr
Further company coverage: BVS.O
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks